Aardvark Therapeutics (NASDAQ:AARD) Rating Lowered to Sell at Wall Street Zen
Aardvark Therapeutics (NASDAQ:AARD – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday. A number of other equities research analysts have also recently issued reports on the stock. Cantor Fitzgerald reiterated an […]
Aardvark Therapeutics (NASDAQ:AARD – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday. A number of other equities research analysts have also recently issued reports on the stock. Cantor Fitzgerald reiterated an […]
